Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Markowitz

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|February 5, 2010
The relationship between scotoma displacement and preferred retinal loci in low-vision patients with age-related macular degenerationSamuel N Markowitz, Natalya Aleykina
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|March 26, 2004
Macular perimetry in low visionSamuel N Markowitz, Charlene Muller
Reviews of Infectious Diseases|March 1, 1987
Use of trimethoprim-sulfamethoxazole in a glucose-6-phosphate dehydrogenase-deficient populationN Markowitz, L D Saravolatz
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|September 8, 2007
Provision and utilization of low-vision rehabilitation services in TorontoKeon Nia, Samuel N Markowitz
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 13, 2006
Image relocation with prisms in patients with age-related macular degenerationRani Al-Karmi, Samuel N Markowitz
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|October 8, 2013
Microperimetry and clinical practice: an evidence-based reviewSamuel N Markowitz, Sophia V Reyes
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 1, 1986
The clinical course in primary angle-closure glaucoma: a reassessmentS N Markowitz, J D Morin
American Journal of Ophthalmology|July 15, 1984
The endothelium in primary angle-closure glaucomaS N Markowitz, J D Morin
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|July 22, 2010
Scotoma size reduction as an adaptive strategy in age-related macular degenerationKevin K Lee, Samuel N Markowitz
Pharmacotherapy|December 29, 2017
Cabozantinib: A Multitargeted Oral Tyrosine Kinase InhibitorJordan N Markowitz, Karen M Fancher
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|February 5, 2010
The relationship between scotoma displacement and preferred retinal loci in low-vision patients with age-related macular degenerationSamuel N Markowitz, Natalya Aleykina
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|March 26, 2004
Macular perimetry in low visionSamuel N Markowitz, Charlene Muller
Reviews of Infectious Diseases|March 1, 1987
Use of trimethoprim-sulfamethoxazole in a glucose-6-phosphate dehydrogenase-deficient populationN Markowitz, L D Saravolatz
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|September 8, 2007
Provision and utilization of low-vision rehabilitation services in TorontoKeon Nia, Samuel N Markowitz
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 13, 2006
Image relocation with prisms in patients with age-related macular degenerationRani Al-Karmi, Samuel N Markowitz
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|October 8, 2013
Microperimetry and clinical practice: an evidence-based reviewSamuel N Markowitz, Sophia V Reyes
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 1, 1986
The clinical course in primary angle-closure glaucoma: a reassessmentS N Markowitz, J D Morin
American Journal of Ophthalmology|July 15, 1984
The endothelium in primary angle-closure glaucomaS N Markowitz, J D Morin
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|July 22, 2010
Scotoma size reduction as an adaptive strategy in age-related macular degenerationKevin K Lee, Samuel N Markowitz
Pharmacotherapy|December 29, 2017
Cabozantinib: A Multitargeted Oral Tyrosine Kinase InhibitorJordan N Markowitz, Karen M Fancher
Pageof 12